logo
Investec Sticks to Their Buy Rating for Bajaj Auto Limited (BAJAJ.AUTO)

Investec Sticks to Their Buy Rating for Bajaj Auto Limited (BAJAJ.AUTO)

In a report released yesterday, Aditya Jhawar from Investec maintained a Buy rating on Bajaj Auto Limited (BAJAJ.AUTO – Research Report), with a price target of INR9,480.00. The company's shares closed last Friday at INR8,607.00.
Confident Investing Starts Here:
Jhawar covers the Consumer Cyclical sector, focusing on stocks such as Bajaj Auto Limited, Tata Motors Limited, and Eicher Motors Limited. According to TipRanks, Jhawar has an average return of 5.1% and a 68.18% success rate on recommended stocks.
In addition to Investec, Bajaj Auto Limited also received a Buy from CLSA's Basudeb Banerjee in a report issued on May 30. However, yesterday, UBS maintained a Sell rating on Bajaj Auto Limited (NSE: BAJAJ.AUTO).
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Godavari Biorefineries share hits 5% upper circuit on Europe patent win for novel anti-cancer molecule
Godavari Biorefineries share hits 5% upper circuit on Europe patent win for novel anti-cancer molecule

Business Upturn

time16 hours ago

  • Business Upturn

Godavari Biorefineries share hits 5% upper circuit on Europe patent win for novel anti-cancer molecule

By Aman Shukla Published on July 4, 2025, 09:31 IST Shares of Godavari Biorefineries surged 5% and hit the upper circuit on July 4, following a key announcement regarding a major breakthrough in its anti-cancer research efforts. In a regulatory filing to the NSE and BSE, the company revealed that it has been granted a European patent for its novel anti-cancer molecule, which has demonstrated high potency against both cancer cells and cancer stem cells. This compound is now officially validated in Spain, the UK, and as a Unitary Patent across Europe. The development falls under the company's 'Anti-Cancer Research Segment', highlighting its focus on cutting-edge oncology innovation. According to the company, this patent not only strengthens its intellectual property portfolio but also reinforces its commitment to developing next-generation cancer therapies. Investors responded positively to the news, sending the stock to its daily upper limit. The development is seen as a significant milestone, potentially opening doors for future collaborations, licensing deals, and expansion into global pharmaceutical markets. This is part of Godavari Biorefineries' broader strategy to diversify into high-value bio-based research areas, beyond its traditional ethanol and bio-chemicals business. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

Apple weighed creating cloud service for developers, Information reports
Apple weighed creating cloud service for developers, Information reports

Business Insider

time20 hours ago

  • Business Insider

Apple weighed creating cloud service for developers, Information reports

Apple (AAPL) previously discussed the idea of creating a business to rent out its cloud servers to the millions of developers that make apps for its devices, The Information's Aaron Tilley reports. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.

Mixed options sentiment in tempus AI Inc Class A with shares up 2.74%
Mixed options sentiment in tempus AI Inc Class A with shares up 2.74%

Business Insider

time20 hours ago

  • Business Insider

Mixed options sentiment in tempus AI Inc Class A with shares up 2.74%

Mixed options sentiment in tempus AI Inc Class A (TEM), with shares up $1.62, or 2.74%, near $60.80. Options volume relatively light with 30k contracts traded and calls leading puts for a put/call ratio of 0.45, compared to a typical level near 0.4. Implied volatility (IV30) dropped 0.82 near 78.31,in the lowest 10% of observations over the past year, suggesting an expected daily move of $3.00. Put-call skew steepened, indicating increased demand for downside protection. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store